115 related articles for article (PubMed ID: 25786619)
1. Gene silencing and antitumoral effects of Eg5 or Ran siRNA oligoaminoamide polyplexes.
Edinger D; Kläger R; Troiber C; Dohmen C; Wagner E
Drug Deliv Transl Res; 2014 Feb; 4(1):84-95. PubMed ID: 25786619
[TBL] [Abstract][Full Text] [Related]
2. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
[TBL] [Abstract][Full Text] [Related]
3. EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery.
Müller K; Klein PM; Heissig P; Roidl A; Wagner E
Nanotechnology; 2016 Nov; 27(46):464001. PubMed ID: 27736810
[TBL] [Abstract][Full Text] [Related]
4. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides.
Fröhlich T; Edinger D; Kläger R; Troiber C; Salcher E; Badgujar N; Martin I; Schaffert D; Cengizeroglu A; Hadwiger P; Vornlocher HP; Wagner E
J Control Release; 2012 Jun; 160(3):532-41. PubMed ID: 22465674
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery.
Steinborn B; Truebenbach I; Morys S; Lächelt U; Wagner E; Zhang W
J Gene Med; 2018 Jul; 20(7-8):e3041. PubMed ID: 29949222
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo.
Klein PM; Kern S; Lee DJ; Schmaus J; Höhn M; Gorges J; Kazmaier U; Wagner E
Biomaterials; 2018 Sep; 178():630-642. PubMed ID: 29580727
[TBL] [Abstract][Full Text] [Related]
8. Targeted siRNA Delivery Using a Lipo-Oligoaminoamide Nanocore with an Influenza Peptide and Transferrin Shell.
Zhang W; Müller K; Kessel E; Reinhard S; He D; Klein PM; Höhn M; Rödl W; Kempter S; Wagner E
Adv Healthc Mater; 2016 Jun; 5(12):1493-504. PubMed ID: 27109317
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran.
Tietze N; Pelisek J; Philipp A; Roedl W; Merdan T; Tarcha P; Ogris M; Wagner E
Oligonucleotides; 2008 Jun; 18(2):161-74. PubMed ID: 18637733
[TBL] [Abstract][Full Text] [Related]
10. Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes.
Troiber C; Edinger D; Kos P; Schreiner L; Kläger R; Herrmann A; Wagner E
Biomaterials; 2013 Feb; 34(5):1624-33. PubMed ID: 23199743
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
12. Combination of active and inactive siRNA targeting the mitotic kinesin Eg5 impairs silencing efficiency in several cancer cell lines.
Formstecher E; Reverdy C; Cholay M; Planquette C; Trouplin V; Lehrmann H; Aresta S; Calabrese A; Arar K; Daviet L; Colland F
Oligonucleotides; 2006; 16(4):387-94. PubMed ID: 17155913
[TBL] [Abstract][Full Text] [Related]
13. Combination of sequence-defined oligoaminoamides with transferrin-polycation conjugates for receptor-targeted gene delivery.
Zhang W; Rödl W; He D; Döblinger M; Lächelt U; Wagner E
J Gene Med; 2015; 17(8-9):161-72. PubMed ID: 26227403
[TBL] [Abstract][Full Text] [Related]
14. Nanosized multifunctional polyplexes for receptor-mediated siRNA delivery.
Dohmen C; Edinger D; Fröhlich T; Schreiner L; Lächelt U; Troiber C; Rädler J; Hadwiger P; Vornlocher HP; Wagner E
ACS Nano; 2012 Jun; 6(6):5198-208. PubMed ID: 22646997
[TBL] [Abstract][Full Text] [Related]
15. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
[TBL] [Abstract][Full Text] [Related]
16. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
17. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
18. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurement of delivery and gene silencing activities of siRNA polyplexes containing pyridylthiourea-grafted polyethylenimines.
Pinel S; Aman E; Erblang F; Dietrich J; Frisch B; Sirman J; Kichler A; Sibler AP; Dontenwill M; Schaffner F; Zuber G
J Control Release; 2014 May; 182():1-12. PubMed ID: 24631860
[TBL] [Abstract][Full Text] [Related]
20. Native chemical ligation for conversion of sequence-defined oligomers into targeted pDNA and siRNA carriers.
Zhang CY; Kos P; Müller K; Schrimpf W; Troiber C; Lächelt U; Scholz C; Lamb DC; Wagner E
J Control Release; 2014 Apr; 180():42-50. PubMed ID: 24566255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
